Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

956 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
Radtke JP, Kuru TH, Bonekamp D, Freitag MT, Wolf MB, Alt CD, Hatiboglu G, Boxler S, Pahernik S, Roth W, Roethke MC, Schlemmer HP, Hohenfellner M, Hadaschik BA. Radtke JP, et al. Among authors: roth w. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):283-91. doi: 10.1038/pcan.2016.16. Epub 2016 May 17. Prostate Cancer Prostatic Dis. 2016. PMID: 27184812
Decoy receptor 3 is a prognostic factor in renal cell cancer.
Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohenfellner M, Kim S, Autschbach F, Schirmacher P, Roth W. Macher-Goeppinger S, et al. Among authors: roth w. Neoplasia. 2008 Oct;10(10):1049-56. doi: 10.1593/neo.08626. Neoplasia. 2008. PMID: 18813347 Free PMC article.
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M, Sykora J, Walczak H, Teh BT, Autschbach F, Herpel E, Schirmacher P, Roth W. Macher-Goeppinger S, et al. Among authors: roth w. Clin Cancer Res. 2009 Jan 15;15(2):650-9. doi: 10.1158/1078-0432.CCR-08-0284. Clin Cancer Res. 2009. PMID: 19147771
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.
Hadaschik BA, Kuru TH, Tulea C, Rieker P, Popeneciu IV, Simpfendörfer T, Huber J, Zogal P, Teber D, Pahernik S, Roethke M, Zamecnik P, Roth W, Sakas G, Schlemmer HP, Hohenfellner M. Hadaschik BA, et al. Among authors: roth w. J Urol. 2011 Dec;186(6):2214-20. doi: 10.1016/j.juro.2011.07.102. Epub 2011 Oct 19. J Urol. 2011. PMID: 22014798
Molecular heterogeneity of TFE3 activation in renal cell carcinomas.
Macher-Goeppinger S, Roth W, Wagener N, Hohenfellner M, Penzel R, Haferkamp A, Schirmacher P, Aulmann S. Macher-Goeppinger S, et al. Among authors: roth w. Mod Pathol. 2012 Feb;25(2):308-15. doi: 10.1038/modpathol.2011.169. Epub 2011 Oct 28. Mod Pathol. 2012. PMID: 22037260 Free article.
Pediatric case report on magnetic resonance imaging/transrectal ultrasound-fusion biopsy of rhabdomyosarcoma of the bladder/prostate: a new tool to reduce therapy-associated morbidity?
Kuru TH, Roethke MC, Nyarangi-Dix J, Okouoyo S, Stockklausner C, Schenk JP, Debus J, Roth W, Teber D, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA. Kuru TH, et al. Among authors: roth w. Urology. 2013 Feb;81(2):417-20. doi: 10.1016/j.urology.2012.10.043. Urology. 2013. PMID: 23374821
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA. Kuru TH, et al. Among authors: roth w. J Urol. 2013 Oct;190(4):1380-6. doi: 10.1016/j.juro.2013.04.043. Epub 2013 Apr 19. J Urol. 2013. PMID: 23608676 Clinical Trial.
Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics.
Kuru TH, Wadhwa K, Chang RT, Echeverria LM, Roethke M, Polson A, Rottenberg G, Koo B, Lawrence EM, Seidenader J, Gnanapragasam V, Axell R, Roth W, Warren A, Doble A, Muir G, Popert R, Schlemmer HP, Hadaschik BA, Kastner C. Kuru TH, et al. Among authors: roth w. BJU Int. 2013 Sep;112(5):568-77. doi: 10.1111/bju.12132. Epub 2013 Jun 17. BJU Int. 2013. PMID: 23773772
956 results